tirzepatide 17.5mg

tirzepatide 17.5mg Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Results were over 72 weeks.

Name: tirzepatide 17.5mg Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Results were over 72 weeks.
Brand: actil.am
SKU: 29978507793
Price: 21.85 USD
Availability: InStock
Rating: 4.7506 (9 reviews)

SKU: 29978507793

4.8

USD21.85 USD53.85

Pay in 4 interest-free payments of $5.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

Of all demographic groups, women between the ages of 50 and 64 had the highest use rate: One in five women, or 20 percent, reported having ever used GLP-1 agonists